123 related articles for article (PubMed ID: 7502709)
1. Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6.
Miyaura C; Kusano K; Masuzawa T; Chaki O; Onoe Y; Aoyagi M; Sasaki T; Tamura T; Koishihara Y; Ohsugi Y
J Bone Miner Res; 1995 Sep; 10(9):1365-73. PubMed ID: 7502709
[TBL] [Abstract][Full Text] [Related]
2. Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy.
Vargas SJ; Naprta A; Lee SK; Kalinowski J; Kawaguchi H; Pilbeam CC; Raisz LG; Lorenzo JA
J Bone Miner Res; 1996 Dec; 11(12):1926-34. PubMed ID: 8970895
[TBL] [Abstract][Full Text] [Related]
3. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice.
Onoe Y; Miyaura C; Ito M; Ohta H; Nozawa S; Suda T
J Bone Miner Res; 2000 Mar; 15(3):541-9. PubMed ID: 10750569
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein 60 causes osteoclastic bone resorption via toll-like receptor-2 in estrogen deficiency.
Koh JM; Lee YS; Kim YS; Park SH; Lee SH; Kim HH; Lee MS; Lee KU; Kim GS
Bone; 2009 Oct; 45(4):650-60. PubMed ID: 19527807
[TBL] [Abstract][Full Text] [Related]
6. Effects of estrogen on tail suspension-induced disuse atrophy in ovariectomized rats: evaluation of the expression of interleukin-6 mRNA in the femur.
Ohmori S; Kanda K; Kawano S; Kambe F; Seo H
Environ Med; 2001 Dec; 45(1):12-4. PubMed ID: 12353531
[TBL] [Abstract][Full Text] [Related]
7. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors.
Torcia M; Lucibello M; Vannier E; Fabiani S; Miliani A; Guidi G; Spada O; Dower SK; Sims JE; Shaw AR; Dinarello CA; Garaci E; Cozzolino F
Exp Hematol; 1996 Jul; 24(8):868-74. PubMed ID: 8690044
[TBL] [Abstract][Full Text] [Related]
8. Production of interleukin 1 beta, a potent bone resorbing cytokine, by cultured human myeloma cells.
Yamamoto I; Kawano M; Sone T; Iwato K; Tanaka H; Ishikawa H; Kitamura N; Lee K; Shigeno C; Konishi J
Cancer Res; 1989 Aug; 49(15):4242-6. PubMed ID: 2787204
[TBL] [Abstract][Full Text] [Related]
9. Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae.
Kawaguchi H; Pilbeam CC; Vargas SJ; Morse EE; Lorenzo JA; Raisz LG
J Clin Invest; 1995 Jul; 96(1):539-48. PubMed ID: 7615826
[TBL] [Abstract][Full Text] [Related]
10. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis.
Pacifici R
J Bone Miner Res; 1996 Aug; 11(8):1043-51. PubMed ID: 8854239
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide-mediated enhancement of bone metabolism in estrogen-deficient mice.
Fujita S; Kikuchi T; Sobue T; Suzuki M; Koide M; Noguchi T
J Periodontol; 2008 Nov; 79(11):2173-81. PubMed ID: 18980527
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.
Kitazawa R; Kimble RB; Vannice JL; Kung VT; Pacifici R
J Clin Invest; 1994 Dec; 94(6):2397-406. PubMed ID: 7989596
[TBL] [Abstract][Full Text] [Related]
13. DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice.
Abdallah BM; Ditzel N; Mahmood A; Isa A; Traustadottir GA; Schilling AF; Ruiz-Hidalgo MJ; Laborda J; Amling M; Kassem M
J Bone Miner Res; 2011 Jul; 26(7):1457-71. PubMed ID: 21308776
[TBL] [Abstract][Full Text] [Related]
14. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts.
Onoe Y; Miyaura C; Kaminakayashiki T; Nagai Y; Noguchi K; Chen QR; Seo H; Ohta H; Nozawa S; Kudo I; Suda T
J Immunol; 1996 Jan; 156(2):758-64. PubMed ID: 8543830
[TBL] [Abstract][Full Text] [Related]
15. High-dose gestagens modulate bone resorption and formation and enhance estrogen-induced endosteal bone formation in the ovariectomized mouse.
Bain SD; Jensen E; Celino DL; Bailey MC; Lantry MM; Edwards MW
J Bone Miner Res; 1993 Feb; 8(2):219-30. PubMed ID: 8442440
[TBL] [Abstract][Full Text] [Related]
16. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice.
Kimble RB; Bain S; Pacifici R
J Bone Miner Res; 1997 Jun; 12(6):935-41. PubMed ID: 9169353
[TBL] [Abstract][Full Text] [Related]
17. Bone-resorbing activity and prostaglandin E produced by human periodontal ligament cells in vitro.
Saito S; Rosol TJ; Saito M; Ngan PW; Shanfeld J; Davidovitch Z
J Bone Miner Res; 1990 Oct; 5(10):1013-8. PubMed ID: 2127873
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of cytokines that modulate bone resorption: effects of age and menopause in women.
McKane WR; Khosla S; Peterson JM; Egan K; Riggs BL
J Bone Miner Res; 1994 Aug; 9(8):1313-8. PubMed ID: 7976512
[TBL] [Abstract][Full Text] [Related]
19. Membrane IL-1 induces bone resorption in organ culture.
Nishihara T; Ishihara Y; Noguchi T; Koga T
J Immunol; 1989 Sep; 143(6):1881-6. PubMed ID: 2789251
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
